Apr 30, 2020
Biomarker Assessment and Targeted Treatment of Nonsquamous Non-Small Cell Lung Cancer — A roundtable discussion with clinical investigators Drs Justin F Gainor, Matthew Gubens, Geoffrey R Oxnard and Heather Wakelee and general medical oncologists Drs Isaac Levy and Estelamari Rodriguez regarding biomarker analysis and...
Apr 30, 2020
Biomarker Assessment and Targeted Treatment of Nonsquamous
Non-Small Cell Lung Cancer (NSCLC) — Slide Presentation 1: Overview
of Targeted Treatment for Metastatic NSCLC — Dr Gubens
CME information and select...
Apr 30, 2020
Biomarker Assessment and Targeted Treatment of Nonsquamous
Non-Small Cell Lung Cancer (NSCLC) — Slide Presentation 2: Liquid
Biopsy in NSCLC: How to Interpret and Apply Results in Clinical
Practice — Dr Oxnard.
CME information and select...
Apr 30, 2020
Biomarker Assessment and Targeted Treatment of Nonsquamous
Non-Small Cell Lung Cancer (NSCLC) — Slide Presentation 3: Optimal
Approach to Metastatic NSCLC with an EGFR Tumor Mutation After
Disease Progression on Osimertinib — Dr Wakelee.
CME information and select...
Apr 30, 2020
Biomarker Assessment and Targeted Treatment of Nonsquamous
Non-Small Cell Lung Cancer (NSCLC) — Slide Presentation 4:
Incidence and Management of Metastatic NSCLC with a RET
Rearrangement — Dr Gainor.
CME information and select...